Dr. Andy Wakefield

[Dr Wakefield was caught up in the vaccine damage fallout from MMR when parents brought him, and his team, their vaccine bowel damaged children. Supported by his hospital, he then said in a public meeting that single vaccines would be a good idea over MMR.  When the shit hit the fan he was thrown to the wolves (by the likes of Professor Zuckerman), and is a perfect example of what happens when you criticise vaccines.  They are now trying to break him (take away his licence and stop him being an expert witness for the vaccine damaged) with a medical kangaroo court.  You can see why medical industry people keep their heads below the parapet, unless they fancy a new job in Australia or the USA.
    He was the perfect man in the right place at the right time as regards truth and the welfare of children.  The vaccine industry couldn't care less about children as their actions demonstrate here, and historically (eg suppressing Vitamin C cure for infections: see).  Read (mostly) Martin Walker's GMC reporting here, especially this recent Interview of Martin Walker. You won't see a better example of medical psychopathy in action.  Historically it reminds one of how they tried to break Dr Hadwen with a manslaughter charge, and you can see the long history of persecuted (mostly cancer) doctors here.   A recent escapee from GMC vaccine tyranny was Dr Jayne Donegan.
     Notice also how the media, especially the BBC, just spews anti-Wakefield propaganda.]

Quotes

Web: http://www.thoughtfulhouse.org/

See: Autism & vaccines  Smearing of Dr Wakefield  Whistleblowers  MMR vaccines

See: Dr Arthur Krigsman  Bryan Jepson, MD

[Oct 2004] Press Release: Thoughtful House scientists make important breakthrough in autism

[Sept 2004] Dr. Wakefield Responds To British Study Clearing MMR Vaccines
MMR Studies that Count, Studies that Don't - F.E. Yazbak, MD, FAAP

[June 19, 2002]  Statement of Andrew Wakefield, M.D., Research Director, International Child Development Resource Center, Palm Bay, Florida

[April 6, 2000] Autism - Present Challenges, Future Needs - Why the Increased Rates?
Testimony pdf   HTML (text only)

Rebuttals
[Jan 2001 MMR] Rebuttal to Wakefield Called 'Weak' with 'Distortions': Shattock

Interviews
CBS News – Research Links Kids Vaccines & Brain Damage  Posted on October 9, 2009 by childhealthsafety . A new scientific safety study by British researcher Dr Laura Hewitson shows US children’s vaccines are linked to brain damage. CBS interviews Dr Andrew Wakefield on this new study and also the controversy over the MMR vaccine and autism.

The Cure Autism Conspiracy of Parents and the M.I.N.D. Institute (Wakefield & Rollens interview)

Media stories
[Media March 2002] Expert says MMR autism link will be proved this year
[Media 3 Feb 2002] PANORAMA MMR Every Parent's Choice
[Media Feb 2002] MMR: Dr Maverick sticks to his guns
[Media 2/12/2001] Anti-MMR doctor is forced out
[Media UK, Dec 2001] Scientists: MMR Vaccine Should Not Have Been Licensed
[Media UK, Jan 2001] Study claims MMR vaccine trials were inadequate
[Media] 'Triple Jag Autism Could Be Next BSE'

170 Cases of Autism Linked to Vaccine in UK

Matthew's story

So What's Not to Like About Andrew Wakefield?
http://www.autism-spectrum.com/vaccine.htm

Dr Wakefield articles/papers
[Nov 2005] The Seat of the Soul; The Origins of the Autism Epidemic by ANDREW WAKEFIELD, MB, BS, FRCS, FRCPath
Andrew J. Wakefielda, FRCS FRCPath; Carol Stottb, PhD; and Kirsten Limbc, BSc
Gastrointestinal comorbidity, autistic regression and Measles-containing vaccines: positive re-challenge and biological gradient
Article-in-press; Medical Veritas: The Journal of Medical Truth; Volume 3, Issue 1, April 2006.
Medical Veritas is the journal of Medical Veritas International (MVI);
www.MedicalVeritas.com.

[pdf] PAUL ASHWOOD,1,5 ANDREW ANTHONY,2 FRANCO TORRENTE,1,3 and ANDREW J. WAKEFIELD4 Spontaneous Mucosal Lymphocyte Cytokine Profiles in Children with Autism and Gastrointestinal Symptoms: Mucosal Immune Activation and Reduced Counter Regulatory Interleukin-10

[Jan 2001] Measles, Mumps, Rubella Vaccine: Through a Glass, Darkly.

[Oct 2004] Press Release: Thoughtful House scientists make important breakthrough in autism

Measles-containing vaccines and IBD-----Andrew Wakefield, 02 January 2002

Detection of Measles Virus Genomic RNA in Cerebrospinal Fluid of Children with Regressive Autism: a Report of Three Cases    J.J. Bradstreet, M.D.; J. El Dahr, M.D.; A. Anthony, M.B., Ph.D.; J.J. Kartzinel, M.D.; A.J. Wakefield, M.B.

Torrente F, Ashwood P, Day R, Machado N, Furlano RI, Anthony A, Davies SE, Wakefield AJ, Thomson MA, Walker-Smith JA, Murch SH.Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism.Mol Psychiatry. 2002;7(4):375-82.PMID: 11986981 [PubMed - in process]
We have reported lymphocytic colitis in children with regressive autism, with epithelial damage prominent. We now compare duodenal biopsies in 25 children with regressive autism to 11 with coeliac disease, five with cerebral palsy and mental retardation and 18 histologically normal controls. Immunohistochemistry was performed for lymphocyte and epithelial lineage and functional markers. We determined the density of intraepithelial and lamina propria lymphocyte populations, and studied mucosal immunoglobulin and complement C1q localisation. Standard histopathology showed increased enterocyte and Paneth cell numbers in the autistic children. Immunohistochemistry demonstrated increased lymphocyte infiltration in both epithelium and lamina propria with upregulated crypt cell proliferation, compared to normal and cerebral palsy controls. Intraepithelial lymphocytes and lamina propria plasma cells were lower than in coeliac disease, but lamina propria T cell populations were higher and crypt proliferation similar. Most strikingly, IgG deposition was seen on the basolateral epithelial surface in 23/25 autistic children, co-localising with complement C1q. This was not seen in the other conditions. These findings demonstrate a novel form of enteropathy in autistic children, in which increases in mucosal lymphocyte density and crypt cell proliferation occur with epithelial IgG deposition. The features are suggestive of an autoimmune lesion.PMID: 11986981 [PubMed - in process]

Uhlmann V, Martin CM, Sheils O, Pilkington L, Silva I, Killalea A, Murch SB, Walker-Smith J, Thomson M, Wakefield AJ, O'Leary JJ. Potential viral pathogenic mechanism for new variant inflammatory bowel disease.Mol Pathol. 2002 Apr;55(2):84-90.PMID: 11950955 [PubMed - in process]

AIMS: A new form of inflammatory bowel disease (ileocolonic lymphonodular hyperplasia) has been described in a cohort of children with developmental disorder. This study investigates the presence of persistent measles virus in the intestinal tissue of these patients (new variant inflammatory bowel disease) and a series of controls by molecular analysis. METHODS: Formalin fixed, paraffin wax embedded and fresh frozen biopsies from the terminal ileum were examined from affected children and histological normal controls. The measles virus Fusion (F) and Haemagglutinin (H) genes were detected by TaqMan reverse transcription polymerase chain reaction (RT-PCR) and the Nucleocapsid (N) gene by RT in situ PCR. Localisation of the mRNA signal was performed using a specific follicular dendritic cell antibody. RESULTS: Seventy five of 91 patients with a histologically confirmed diagnosis of ileal lymphonodular hyperplasia and enterocolitis were positive for measles virus in their intestinal tissue compared with five of 70 control patients. Measles virus was identified within the follicular dendritic cells and some lymphocytes in foci of reactive follicular hyperplasia. The copy number of measles virus ranged from one to 300,00 copies/ng total RNA. CONCLUSIONS: The data confirm an association between the presence of measles virus and gut pathology in children with developmental disorder.

Wakefield AJ.      MMR vaccination and autism. Lancet. 1999 Sep 11;354(9182):949-50. No abstract available.PMID: 10489978; UI: 99418510.

(Adverse Drug Reactions 2000,19(4) 1-19. Authors: Andrew J Wakefield FRCS, Scott M Montgomery PhD.)

A J Wakefield, S H Murch, A Anthony, J Linnell, D M Casson, M Malik, M Berelowitz, A P Dhillon, M A Thomson, P Harvey, A Valentine, S E Davies, J A Walker-SmithVolume 351, Number 9103 28 February 1998 Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children
 

American Journal of Gastroenterology, September, 2000
 
  Original Contribution
  September 2000
  Volume 95, Number 9
  Pages 2285-2295      
       
 
  A. J. Wakefield, F.R.C.S.,a,b A. Anthony, M.Sc., Ph.D., M.B.B.S.,b S. H.
  Murch, Ph.D., F.R.C.P., F.R.C.P.C.H.,b M. Thomson, MB.ChB., M.R.C.P.,
  F.R.C.P.C.H.,c S. M. Montgomery, Ph.D.,c S. Davies, M.R.C.Path.,b J. J.
  O'Leary, M.D., D.Phil., M.R.C.Path.,b M. Berelowitz, F.R.C.Psych.,e and J.
  A. Walker-Smith, M.D., F.R.C.P., F.R.A.C.P., F.R.C.P.C.H.d
 
  OBJECTIVE: Intestinal pathology, i.e., ileocolonic lymphoid nodular
  hyperplasia (LNH) and mucosal inflammation, has been described in children
  with developmental disorders. This study describes some of the endoscopic
  and pathological characteristics in a group of children with developmental
  disorders (affected children) that are associated with behavioral regression
  and bowel symptoms, and compares them with pediatric controls.
  METHODS: Ileocolonoscopy and biopsy were performed on 60 affected children
  (median age 6 yr, range 3-16; 53 male). Developmental diagnoses were autism
  (50 patients), Asperger's syndrome (five), disintegrative disorder (two),
  attention deficit hyperactivity disorder (ADHD) (one), schizophrenia (one),
  and dyslexia (one). Severity of ileal LNH was graded (0-3) in both affected
  children and 37 developmentally normal controls (median age 11 yr, range
  2-13 yr) who were investigated for possible inflammatory bowel disease
  (IBD). Tissue sections were reviewed by three pathologists and scored on a
  standard proforma. Data were compared with ileocolonic biopsies from 22
  histologically normal children (controls) and 20 children with ulcerative
  colitis (UC), scored in an identical manner. Gut pathogens were sought
  routinely.
  RESULTS: Ileal LNH was present in 54 of 58 (93%) affected children and in
  five of 35 (14.3%) controls (p < 0.001). Colonic LNH was present in 18 of 60
  (30%) affected children and in two of 37 (5.4%) controls (p < 0.01).
  Histologically, reactive follicular hyperplasia was present in 46 of 52
  (88.5%) ileal biopsies from affected children and in four of 14 (29%) with
  UC, but not in non-IBD controls (p < 0.01). Active ileitis was present in
  four of 51 (8%) affected children but not in controls. Chronic colitis was
  identified in 53 of 60 (88%) affected children compared with one of 22
  (4.5%) controls and in 20 of 20 (100%) with UC. Scores of frequency and
  severity of inflammation were significantly greater in both affected
  children and those with UC, compared with controls (p < 0.001).
  CONCLUSIONS: A new variant of inflammatory bowel disease is present in this
  group of children with developmental disorders.
  Cite this article as: . Wakefield AJ, Anthony A, Murch SH, Thomson M,
  Montgomery SM, Davies S, O'Leary JJ, Phil D, Berelowitz M and Walker-Smith
  JA. Enterocolitis in Children With Developmental Disorders. Am J
  Gastroenterol September;95:2285-2295.
  aUniversity Departments of Medicine, bHistopathology, cPaediatric
  Gastroenterology, and dPaediatric Psychiatry, Royal Free and eUniversity
  College Medical School, Royal Free Campus, London, United Kingdom, and
  University Department of Pathology, Coombe Women's Hospital and Trinity
  College, Dublin, Eire